L. Westover

发表

Synthesis and discovery of macrocyclic polyoxygenated bis-7-azaindolylmaleimides as a novel series of potent and highly selective glycogen synthase kinase-3beta inhibitors.

S. Emanuel, P. Connolly, L. Jolliffe, 2003, Journal of medicinal chemistry.

3-(7-Azaindolyl)-4-arylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3.

J. Li, H. Ye, C. Derian, 2004, Bioorganic & medicinal chemistry letters.

3-(7-Azaindolyl)-4-arylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3.

J. Li, H. Ye, C. Derian, 2004, Bioorganic & medicinal chemistry letters.

Phosphorylation Validation of a Cell-Based Screen for Insulin Receptor Modulators by Quantification of Insulin Receptor

B. Conway, L. Minor, K. Demarest, 2013 .

Validation of a Cell-Based Screen for Insulin Receptor Modulators by Quantification of Insulin Receptor Phosphorylation

M. Wildey, B. Conway, L. Minor, 2003, Journal of biomolecular screening.

Use of the Sanz pipet in the clinical laboratory.

L. Westover, A. G. Ware, M. Wertman, 1962, Clinical chemistry.

The determination of serum magnesium by the molybdivanadate method for phosphate.

L. Westover, D. G. Simonsen, M. Wertman, 1947, The Journal of biological chemistry.

Design, synthesis, and biological evaluation of novel 7-azaindolyl-heteroaryl-maleimides as potent and selective glycogen synthase kinase-3β (GSK-3β) inhibitors

G. Kuo, B. Maryanoff, W. Murray, 2004 .

In vivo characterization of a dual adenosine A2A/A1 receptor antagonist in animal models of Parkinson's disease.

K. Rhodes, B. Shook, Xun Li, 2010, Journal of medicinal chemistry.

Substituted thieno[2,3-d]pyrimidines as adenosine A2A receptor antagonists.

M. T. Powell, K. Rhodes, B. Shook, 2013, Bioorganic & medicinal chemistry letters.

Methylene amine substituted arylindenopyrimidines as potent adenosine A(2A)/A(1) antagonists.

K. Rhodes, B. Shook, Xun Li, 2010, Bioorganic & medicinal chemistry letters.

Etiology and treatment of serum potassium deficits.

T. Reynolds, H. Edmondson, L. Westover, 1951, Journal of the American Medical Association.

Synthesis and biological evaluation of novel macrocyclic bis-7-azaindolylmaleimides as potent and highly selective glycogen synthase kinase-3β (GSK-3β) inhibitors☆

Xin Chen, C. Prouty, M. P. Beavers, 2004 .

Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 Inhibitors.

Charles Y. Lin, S. Knapp, T. Westbrook, 2020, Cell chemical biology.

Macrocyclic bisindolylmaleimides as inhibitors of protein kinase C and glycogen synthase kinase-3.

S. Emanuel, H. Ye, C. Derian, 2003, Bioorganic & medicinal chemistry letters.

Design and characterization of optimized adenosine A₂A/A₁ receptor antagonists for the treatment of Parkinson's disease.

M. T. Powell, K. Rhodes, B. Shook, 2012, Journal of medicinal chemistry.

THE TREATMENT OF ACUTE ANURIA. WITH EVALUATION OF PERITONEAL LAVAGE

L. Westover, D. G. Simonsen, M. Wertman, 1949, Annals of surgery.

Accelerating Lead Identification by High Throughput Virtual Screening: Prospective Case Studies from the Pharmaceutical Industry

John J. M. Wiener, Nidhi Arora, James P Edwards, 2019, J. Chem. Inf. Model..

Discovery of a dihydropyrimidine series of molecules that selectively mimic the biological actions of calcitonin.

R. Rivero, Jun Z. Xu, K. Demarest, 2004, Bioorganic & medicinal chemistry letters.

Aminomethyl substituted thieno[2,3-d]pyrimidines as adenosine A2A receptor antagonists

K. Rhodes, B. Shook, R. Scannevin, 2011 .

Synthesis and biological evaluation of novel macrocyclic bis-7-azaindolylmaleimides as potent and highly selective glycogen synthase kinase-3 beta (GSK-3 beta) inhibitors.

Xin Chen, C. Prouty, M. P. Beavers, 2004, Bioorganic & Medicinal Chemistry.

Optimization of arylindenopyrimidines as potent adenosine A(2A)/A(1) antagonists.

K. Rhodes, B. Shook, Xun Li, 2010, Bioorganic & medicinal chemistry letters.